HLTH - VanEck Vectors Global Healthcare Leaders ETF

VanEck Blog & Insights

VanEck Vectors Global Healthcare Leaders ETF HLTH

Fund description: HLTH gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index. 

Index description: The MarketGrader Developed Markets (ex-Australia) Health Care Index consists of 50 fundamentally sound companies with the best growth at a reasonable price (GARP) attributes in the healthcare sector from developed markets excluding Australia.

Management style:  Replication

Country of domicile: Australia

 as at 29-Oct-20

  • Exchange

    ASX
  • ASX code

    HLTH
  • Bloomberg index code

    MGHCAUNR
  • Index provider

    MarketGrader
  • NAV1

    $10.28
  • Units outstanding1

    2,000,000
  • Net assets1

    $20.6M
  • Number of holdings1

    50
  • Inception date2

    08-Sep-20
  • ASX commencement

    10-Sep-20
1As of the close of the previous trading day.
2The date the ETF was seeded prior to quotation on ASX.

as at 29-Oct-20

*The NAV is generally calculated daily after all markets are closed for that day based on the closing price of the securities on the relevant foreign stock exchange. The NAV is then converted to AUD based on the relevant London WM Reuters 4pm exchange rate. This means, due to Australia’s time zone, that the NAV will generally not be updated until around 12pm next business day. 

 

Key benefits

Global growth opportunity
A sector with significant growth potential due to shifting global demographics, social changes, research & development and innovation supporting increased demand in healthcare-related products and services

A portfolio of global healthcare leaders comprising the most fundamentally strong companies
Invests in 50 fundamentally sound and attractively valued companies with the best growth prospects in the healthcare sector

Targeted exposure and diversification
A portfolio which targets focused exposure to healthcare and offers true diversification by equally weighting across companies

Trading information

  • ASX code

    HLTH
  • IRESS code

    HLTH.AXW
  • Units outstanding

    2,000,000
  • ISIN

    AU0000102683

Fees and other costs  

  • Management costs p.a.

    0.45%

Key risks

An investment in the ETF carries risks associated with: ASX trading time differences, financial markets generally, individual company management, industry sectors, foreign currency, currency hedging, country or sector concentration, political, regulatory and tax risks, fund operations, liquidity and tracking an index. See the PDS for details.

Prices as at  29-Oct-20

NAV/
Last trade
Volume:
30-day avg/
Previous day
Daily change: NAV/
Last trade
YTD change:
NAV/
Last trade
Premium/
Discount
Premium/
Discount
Distribution charts
NAV &
Premium /Discount
History
NAV
Chart
HLTH $10.28
$10.33
42,729
10,731
$0.07 / +0.72%
$-0.04 / -0.39%
+3.38%
--
$0.05
+0.46%

Performance history (%) View all ETFs » View all indices »

1 Mth 3 Mths 6 Mths 1 Yr 3 Yrs p.a. 5 Yrs p.a. 10 Yrs p.a. ETF Inception p.a.
Price return -- -- -- -- -- -- -- 3.18
Income return -- -- -- -- -- -- -- 0.00
Total return -- -- -- -- -- -- -- 3.18
Index (MGHCAUNR) 1.97 2.05 10.37 30.19 22.23 17.53 21.81 3.25
1 Mth 3 Mths 6 Mths 1 Yr 3 Yrs p.a. 5 Yrs p.a. 10 Yrs p.a. ETF Inception p.a.
Price return -- -- -- -- -- -- -- 3.18
Income return -- -- -- -- -- -- -- 0.00
Total return -- -- -- -- -- -- -- 3.18
Index (MGHCAUNR) 1.97 2.05 10.37 30.19 22.23 17.53 21.81 3.25

Top ten holdings (%) View all daily holdings » as at 30-Sep-20

No. of holdings: 50
Holding name
Ticker
No. of securities held Market value % of Fund
net assets
DIASORIN SPA
DIA IM
1,006 282,927 2.30
HOLOGIC INC
HOLX US
2,973 275,710 2.24
PERKINELMER INC
PKI US
1,529 267,743 2.17
HOYA CORP
7741 JP
1,700 266,557 2.16
HORIZON THERAPEUTICS PLC
HZNP US
2,457 266,285 2.16
STERIS PLC
STE US
1,077 264,746 2.15
MASIMO CORP
MASI US
794 261,502 2.12
THERMO FISHER SCIENTIFIC INC
TMO US
422 259,953 2.11
ICON PLC
ICLR US
971 258,875 2.10
IDEXX LABORATORIES INC
IDXX US
470 257,777 2.09
BIO-RAD LABORATORIES INC
BIO US
358 257,460 2.09
ROYALTY PHARMA PLC
RPRX US
4,386 257,439 2.09
ZOETIS INC
ZTS US
1,115 257,255 2.09
NOVO NORDISK A/S
NOVOB DC
2,631 254,065 2.06
EISAI CO LTD
4523 JP
2,000 253,416 2.06
DEXCOM INC
DXCM US
440 253,061 2.05
ALEXION PHARMACEUTICALS INC
ALXN US
1,583 252,728 2.05
BIOGEN INC
BIIB US
637 252,116 2.05
AMGEN INC
AMGN US
710 251,767 2.04
VERTEX PHARMACEUTICALS INC
VRTX US
662 251,334 2.04
SARTORIUS STEDIM BIOTECH
DIM FP
520 250,632 2.04
WEST PHARMACEUTICAL SERVICES INC
WST US
652 250,066 2.03
MOLINA HEALTHCARE INC
MOH US
978 249,757 2.03
LONZA GROUP AG
LONN SW
289 249,540 2.03
ONO PHARMACEUTICAL CO LTD
4528 JP
5,700 248,984 2.02
GENMAB A/S
GMAB DC
490 247,706 2.01
CATALENT INC
CTLT US
2,061 246,314 2.00
PFIZER INC
PFE US
4,766 244,035 1.98
METTLER-TOLEDO INTERNATIONAL INC
MTD US
181 243,880 1.98
HUMANA INC
HUM US
422 243,686 1.98
UNITEDHEALTH GROUP INC
UNH US
557 242,282 1.97
JOHNSON & JOHNSON
JNJ US
1,163 241,573 1.96
DAVITA INC
DVA US
2,015 240,788 1.96
ANTHEM INC
ANTM US
641 240,204 1.95
RESMED INC
RMD US
999 238,938 1.94
REGENERON PHARMACEUTICALS INC
REGN US
305 238,204 1.93
MERCK & CO INC
MRK US
2,055 237,827 1.93
ELI LILLY AND CO
LLY US
1,147 236,873 1.92
CHUGAI PHARMACEUTICAL CO LTD
4519 JP
3,800 236,876 1.92
RECORDATI INDUSTRIA CHIMICA E FARMACEUT
REC IM
3,305 236,511 1.92
OTSUKA HOLDINGS CO LTD
4578 JP
4,000 235,224 1.91
FISHER & PAYKEL HEALTHCARE CORP LTD
FPH NZ
7,631 234,136 1.90
ROCHE HOLDING AG
RO SW
486 233,364 1.89
CHEMED CORP
CHE US
348 233,222 1.89
ABBVIE INC
ABBV US
1,898 231,944 1.88
GLAXOSMITHKLINE PLC
GSK LN
8,807 230,653 1.87
CSPC PHARMACEUTICAL GROUP LTD
1093 HK
84,000 226,830 1.84
SAMSUNG BIOLOGICS CO LTD
207940 KS
262 215,666 1.75
NEUROCRINE BIOSCIENCES INC
NBIX US
1,560 209,291 1.70
CELLTRION INC
068270 KS
639 196,295 1.59
OTHER/CASH
--
1,923 0.02
Top ten total (%) 99.96
These are not recommendations to buy or to sell any security.

Top 10 Country weightings (%) as at 30-Sep-20

  • Country

    Weightings (%)
  • United States

    64.6
  • Japan

    10.1
  • Italy

    4.2
  • Denmark

    4.1
  • Switzerland

    3.9
  • South Korea

    3.3
  • Ireland

    2.1
  • France

    2.0
  • New Zealand

    1.9
  • United Kingdom

    1.9
  • China

    1.8
  • Other/Cash

    0.0
  • Total

    99.9

Sub-sector weightings (%) as at 30-Sep-20

  • Sector

    Weightings (%)
  • Pharmaceuticals

    33.6
  • Health Care Equipment & Supplies

    21.0
  • Biotechnology

    17.3
  • Life Sciences Tools & Services

    16.3
  • Health Care Providers & Services

    11.8
  • Other/Cash

    0.0
  • Total

    100.0